Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype.

about

Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype.

Item

http://www.wikidata.org/entity/Q47218550

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype.

@en

Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype.

@nl

type

Item

label

Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype.

@en

Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype.

@nl

prefLabel

Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype.

@en

Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype.

@nl

P1476

Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype

@en

P2093

Angela Buonadonna

http://www.w3.org/2001/XMLSchema#string

Debora Basile

http://www.w3.org/2001/XMLSchema#string

Lara Alessandrini

http://www.w3.org/2001/XMLSchema#string

Mara Fornasarig

http://www.w3.org/2001/XMLSchema#string

Mariangela De Zorzi

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of gastric cancer

Genomic alterations and molecular subtypes of gastric cancers in Asians

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Arlequin (version 3.0): an integrated software package for population genetics data analysis

Comprehensive molecular characterization of gastric adenocarcinoma

THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION

SNP analysis to results (SNPator): a web-based environment oriented to statistical genomics analyses upon SNP data.

Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer.

Molecular classifications of gastric cancers: Novel insights and possible future applications.

HER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance.

P31

scholarly article

P356

10.3390/IJMS19010047

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Davide Adriano Santeufemia

P577

2017-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29295527

http://www.w3.org/2001/XMLSchema#string

P932

5795997

http://www.w3.org/2001/XMLSchema#string